$10

Therapy and Research in Psychedelic Science (TRIPS) Seminar Series

Actions and Detail Panel

$10

Event Information

Share this event

Date and time

Location

Location

Online event

Event description
TRIPS focuses on educating healthcare professionals about the latest innovations in therapy and research in psychedelic science.

About this event

TRIPS seminar series hosts speakers discussing scientifically-oriented presentations and discussions about psychedelics to educate healthcare professionals. This series was created to guide healthcare providers and students preparing to be professionals towards the most relevant, pragmatic, and essential information about psychedelic-assisted therapy, changing legal statuses, and harm reduction approaches in order to better serve clients and communities.

This seminar series is a fundraiser for our clinical trial of MDMA-assisted psychotherapy for social anxiety disorder that Portland Psychotherapy investigators plan to begin in the Fall of 2021. All proceeds after presenter remuneration will go to fund this clinical trial.

These presentations are hosted through Zoom. Each presentation will be approximately 30 minutes with a 30-minute discussion afterward. Presentations will be recorded and sent to anyone who registers for the event. The recording will be available for 30 days after it has been sent to registered attendees.

Cancellation Policy: We charge a $10 administration fee for cancellations made by participants more than two weeks before the training event. For cancellations within two weeks of the training event, we will refund 50% of the tuition after subtracting the administration fee. Alternately, participants may elect to apply 100% of their tuition to a future TRIPS training event. No refunds will be given after training events.

Upcoming Events:

September 10th, 2021 - Cultural Considerations in Outreach to and Assessment of Minoritized/Marginalized Individuals in Psychedelic-Assisted Psychotherapy with Terence Ching, Ph.D.

With the psychedelic renaissance gaining momentum, there is growing consensus that in order to conduct psychedelic-assisted psychotherapy ethically and equitably, there is a need to improve minoritized or marginalized individuals’ access to these therapies. This presentation will first cover some barriers to access among communities traditionally underrepresented in the above-ground of psychedelic-assisted psychotherapy. Next, these barriers to access will be contextualized as extrapharmacological factors (i.e., set and setting) that may influence the process and outcomes of psychedelic-assisted psychotherapy. Lastly, this presentation will discuss how to assess some culturally relevant factors which may be implicated in the presenting complaints of individuals seeking psychedelic-assisted psychotherapy. *Note about content: This presentation stems from the lived experiences and professional training of the presenter, and necessarily covers only a small and nuanced part of the bigger diversity, equity, and inclusion picture in the context of psychedelic-assisted psychotherapy. It is encouraged for attendees to continue practicing cultural humility as they endeavor to decolonize and diversify their own practice of psychedelic-assisted psychotherapy.

Terence H. W. Ching received his Ph.D. in Clinical Psychology from the University of Connecticut. He is currently a postdoctoral associate at the Yale OCD Research Clinic. Prior to moving to the United States, Terence received his BS and MS in Psychology from the National University of Singapore. Terence has clinical and research interests at the intersections of OCD and clinical anxiety, trauma and PTSD, cultural diversity, and psychedelic-assisted psychotherapy for difficult-to-treat mental disorders. Terence has given talks and published several peer-reviewed journal articles in these areas and continues to serve as an ad-hoc reviewer for multiple journals based on these topics. He is a member of several regional and national professional psychological associations, including the Connecticut Psychological Association, the Association for Behavioral and Cognitive Therapies, the International OCD Foundation, and the Anxiety and Depression Association of America. Terence has also received training in MDMA-assisted psychotherapy for PTSD by the Multidisciplinary Association for Psychedelic Sciences (MAPS) and co-facilitated the first MAPS MDMA-assisted psychotherapy training for therapists of color in 2019. Terence is invested in queering and diversifying psychedelic research and clinical programs. He is also dedicated to improving access to these spaces for BIPOC, LGBTQ, and other marginalized groups, to empower them to collectively heal from cultural traumas and discrimination-related stress accrued from living in a racist and cis-/heteronormative world.

____________________________________________________________________________________________

October 8th, 2021 - Presentation Title TBA - Dr. Elizabeth Nielson

____________________________________________________________________

November 12th, 2021 - Presentation Title TBA - Anthony Bossis, Ph.D.

____________________________________________________________________

December 10th, 2021 - Presentation Title TBA - Jamilah R. George

____________________________________________________________________

January 14th, 2022 - Presentation Title TBA - Jordan Sloshower, MD, MSc

More dates will be announced soon!

Previous Events:

December 11th, 2020 - Ethical and Legal Considerations in Providing Psychedelic Integration Therapy with Brian Pilecki, Ph.D. and Jason Luoma, Ph.D.

January 8th, 2021 - What's It Like to Trip? The Patient Experience in Psychedelic-Assisted Therapy with Brian Pilecki, Ph.D.

February 12th, 2021 - Returning From All: Integrating 5-MeO-DMT Experiences in Psychotherapy with Rafael Lancelotta, M.S.

March 12th, 2021 - What does Psilocybin-Assisted Therapy for Depression Look Like? A Clinical Case Presentation based on a Recent Clinical Trial from Johns Hopkins with Alan K. Davis, Ph.D.

April 9th, 2021 - Ketamine 101: An Introduction to Ketamine-Assisted Psychotherapy with Gregory Wells, Ph.D.

May 14th, 2021 - Research on MDMA and Psychedelic-Assisted Therapy: An Overview of the Evidence for Clinicians with Jason Luoma, Ph.D.

June 11th, 2021- Becoming a Psychedelic-Informed Therapist: Toward Developing Your Own Practice with Nathan Gates, M.A., LCPC

Get Our Newsletter

Additional events for 2021 will be announced as they are scheduled. If you would like to stay up to date on information about TRIPS, you can join our newsletter here.

Portland Psychotherapy is also hosting an Ethical and Legal Considerations in Psychedelic Integration Therapy course in May of 2021. Check it out and sign up for it here.

Share with friends

Date and time

Location

Online event

{ _('Organizer Image')}

Organizer Portland Psychotherapy - Clinic, Research, & Training Center

Organizer of Therapy and Research in Psychedelic Science (TRIPS) Seminar Series

Portland Psychotherapy provides psychotherapy services, classes for personal growth, conducts scientific research, and provides training for professionals in evidence based psychotherapy approaches.

Save This Event

Event Saved